Risk factors for infliximab-induced infusion reactions based on a retrospective study of medical information
{{output}}
Objective: Infliximab is indicated for a wide range of diseases, and infusion reactions (IRs) have been reported after infliximab administration in 17.6% of patients in clinical practice. This study aimed to identify the risk fac... ...
